Joshua Lakoff

Postoperative thyroglobulin antibodies in differentiated thyroid cancer: predictors and associations with persistent and recurrent disease

Anti-thyroglobulin antibodies (TgAb) are present in up to 25% of patients with differentiated thyroid cancer (DTC) and interfere with thyroglobulin (Tg) measurement, a key biomarker used to monitor for persistent or recurrent disease (PRD). Despite its clinical significance, risk...